FDA holds up approval of Alexza's anti-psychotic drug | Reuters

Links shared publicly online about this topic.

  • 809
    total visits

FDA holds up approval of Alexza's anti-psychotic drug | Reuters

reuters.com

BANGALORE (Reuters) - U.S. health regulators declined to approve Alexza Pharmaceuticals Inc's drug to treat agitation in patients with schizophrenia or bipolar disorder, potentially delaying approval of

View full resource at reuters.com

Tags: Schizophrenia, Antipsychotic Medication, Psychotic Disorder, Drug, Pharma, Healthy Living, FDA

  • Share

Most Recently Shared on October 11, 2010 at 7:25 pm By:

FibroidDoctor Bruce McLucas, MD

FDA holds up approval of Alexza's anti-psychotic drug http://ow.ly/19oEMg

2 years ago...

Advertisement